13/06/2026
Lymphoma Coalition will be participating in the European Hematology Association (EHA) 2026 Congress, taking place from 11–14 June 2026 in Stockholm, Sweden.
The annual congress brings together healthcare professionals, researchers, patient advocates, and organisations from across the global haematology community.
Lorna Warwick, CEO of Lymphoma Coalition, will participate as a panellist in the “Women in CAR T” side event on Thursday, 11 June 2026, from 8 PM–10 PM in Stockholm.
As part of the official EHA programme, Lorna and Natacha Bolaños, Head of Membership & Alliances, will participate in the EHA Symposium on Patient-HCP Communication on Saturday, 13 June. The symposium will feature a multidisciplinary panel of experts discussing ways to optimise communication with the goal of improving patient-centred care. Natacha will also participate in several EHA Patient Advocacy Committee (PAC) meetings and patient-focused sessions throughout the event.
Lymphoma Coalition also had a research abstract accepted for publication at EHA 2026: Incidence and Impact of Misdiagnosis in Diffuse Large B-Cell Lymphoma (DLBCL). The abstract explores patient-reported experiences related to misdiagnosis and its impact on individuals living with DLBCL.
Read the abstract here: https://lymphomacoalition.org/research-lymphoma/
Lymphoma Coalition looks forward to participating in EHA 2026 and engaging with the global haematology community in Stockholm.
